KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$250.0 million.

  • Amgen's Gains from Investment Securities fell 75789.47% to -$250.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$149.0 million, marking a year-over-year decrease of 18418.08%. This contributed to the annual value of -$149.0 million for FY2025, which is 18418.08% down from last year.
  • According to the latest figures from Q4 2025, Amgen's Gains from Investment Securities is -$250.0 million, which was down 75789.47% from $28.0 million recorded in Q3 2025.
  • Amgen's 5-year Gains from Investment Securities high stood at $856.0 million for Q4 2023, and its period low was -$492.0 million during Q3 2023.
  • Over the past 5 years, Amgen's median Gains from Investment Securities value was $7.0 million (recorded in 2022), while the average stood at $43.5 million.
  • As far as peak fluctuations go, Amgen's Gains from Investment Securities skyrocketed by 142142.86% in 2022, and later plummeted by 536666.67% in 2023.
  • Over the past 5 years, Amgen's Gains from Investment Securities (Quarter) stood at $28.0 million in 2021, then soared by 1421.43% to $426.0 million in 2022, then skyrocketed by 100.94% to $856.0 million in 2023, then plummeted by 95.56% to $38.0 million in 2024, then crashed by 757.89% to -$250.0 million in 2025.
  • Its last three reported values are -$250.0 million in Q4 2025, $28.0 million for Q3 2025, and $23.0 million during Q2 2025.